🎥 In a recent interview, the lovely Dr Jennifer O'Sullivan discussed cardiovascular safety and management of CV events when treating patients with JAK inhibitors, providing a UK perspective.

Click here to watch:
👉 buff.ly/SaGiSRO

#ESHCMLMPN2025 #MPNsm #HemOnc #BloodSky #HemeSky #MedSky

We recently had the pleasure of speaking with Daniela Žáčková to hear about TKI dose reduction before treatment-free remission in patients with CML.

Want to learn more?

Watch the interview here:
🎥 buff.ly/QEvhmwm

#CMLsm #Leusm #HemOnc #ESHCMLMPN2025 #MedSky #BloodSky #HemeSky

At #ESHCMLMPN2025, Daniel Wiseman gave an insightful case-based presentation in which he utilized two real-world cases from his clinical practice to discuss the current management of CMML.

Click to hear more:
👉 buff.ly/pchdJze

#Leusm #RareDisease #CMML #Hematology #MedSky #BloodSky #HemeSky

Don't forget to check our exclusive virtual coverage of the recent ESH CML/MPN meeting if you want to hear the latest in CML, MPN, & CMML!🩸

Click here to explore:

🎥 buff.ly/ENlF9MF

#CMLsm #MPNsm #Leusm #ESHCMLMPN2025 #Hematology #MedSky #BloodSky #HemeSky

Why is it important to integrate quality of life assessment for patients with heme malignancies into both clinical trials & routine practice?

Fabio Efficace discussed this in his keynote at #ESHCMLMPN2025.

Click here to learn more:
👉 buff.ly/DwHNziX

#HemOnc #BloodSky #HemeSky

It was great speaking with Michael Loschi to hear about a session on combination therapy in #myelofibrosis at the recent #ESHCMLMPN2025 meeting.

Click here to watch the interview:
👉 buff.ly/KsW7568 👈

#MPNsm #HemOnc #BloodSky #HemeSky #MedSky